Recall Register

PAI Holdings, LLC. dba Pharmaceutical Associates Inc: FDA recalls

FDA enforcement reports name PAI Holdings, LLC. dba Pharmaceutical Associates Inc as the recalling firm in 5 events. The events have 7 product records. The recalls started from 2020 to 2025. All the events are drug recalls.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

5 events, newest first.

FDA enforcement events of PAI Holdings, LLC. dba Pharmaceutical Associates Inc
InitiatedProduct (first record)TypeClassRecordsStatus
7 Jan 2025Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16DrugClass III1Terminated
29 Jul 2021Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, Rx ONLY, packaged in a) 16 fl oz (473 mL) NDC 0121-0868-16; b) 2 fl oz (60 mL) NDC 0121-0868-02; Manufactured by: Pharmaceutical Associates, Inc. Greenville, SC 29605DrugClass II3Terminated
9 Sep 2020Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Pharmaceutical Associates, Inc. Greenville, SC 29605 NDC 0121-1696-40DrugClass III1Terminated
4 Aug 2020Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0810-16DrugClass II1Terminated
19 Mar 2020Nystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, Rx ONLY, pai Pharmaceutical Associates, Inc., Greenville, SC 29605; NDC 0121-0810-16.DrugClass II1Terminated

An event with 1 product record and a class that is not Class I has no page. It has a row in this table.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Recalling firm: The firm that the FDA record names for a recall.

Type and class

PAI Holdings, LLC. dba Pharmaceutical Associates Inc: events for each product type
TypeEvents
Drug5
PAI Holdings, LLC. dba Pharmaceutical Associates Inc: events in each class
ClassEvents
Class II3
Class III2
Share of the events of the firm in Class I
0%
Share of all events on the register in Class I
18%
Events with the status Ongoing
0

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of PAI Holdings, LLC. dba Pharmaceutical Associates Inc, by the year that the recall started. The largest year is 2020, with 3 events.

Official channels

Cite this page

Recall Register. PAI Holdings, LLC. dba Pharmaceutical Associates Inc: FDA recalls. https://recallregister.com/firm/pai-holdings-llc-dba-pharmaceutical-associates-inc/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
State of the firm address
SC

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not compare one firm with a different firm. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of PAI Holdings, LLC. dba Pharmaceutical Associates Inc have?
Class II: 3 events. Class III: 2 events. The class is for the product of a recall. It is not a class of the firm.
What is the newest FDA recall of PAI Holdings, LLC. dba Pharmaceutical Associates Inc?
FDA event 96119, which the firm started on 7 Jan 2025. The first product in the record is: Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16
How many FDA recalls of PAI Holdings, LLC. dba Pharmaceutical Associates Inc have the status Ongoing?
No event has the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.